CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 275 filers reported holding CANTEL MEDICAL CORP in Q1 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,069,000 | -5.8% | 14,296 | +1.5% | 0.08% | 0.0% |
| Q2 2019 | $1,135,000 | +20.5% | 14,079 | 0.0% | 0.08% | +17.4% |
| Q1 2019 | $942,000 | -99.9% | 14,079 | 0.0% | 0.07% | -18.8% |
| Q4 2018 | $1,048,182,000 | -42.8% | 14,079 | -29.3% | 0.08% | -28.0% |
| Q3 2018 | $1,832,638,000 | -77.3% | 19,907 | -75.7% | 0.12% | -79.8% |
| Q2 2018 | $8,064,045,000 | -48.0% | 81,985 | -41.1% | 0.58% | -49.9% |
| Q1 2018 | $15,520,304,000 | +375.5% | 139,308 | +339.1% | 1.16% | +357.9% |
| Q4 2017 | $3,263,757,000 | +340.0% | 31,727 | +302.8% | 0.25% | +303.2% |
| Q3 2017 | $741,777,000 | +28.5% | 7,877 | +6.3% | 0.06% | +18.9% |
| Q2 2017 | $577,157,000 | +55.1% | 7,408 | +59.5% | 0.05% | +43.2% |
| Q1 2017 | $372,065,000 | +23.6% | 4,645 | +6.0% | 0.04% | -9.8% |
| Q2 2016 | $301,106,000 | -68.8% | 4,381 | -67.6% | 0.04% | -69.6% |
| Q1 2016 | $963,645,000 | +82.1% | 13,504 | +58.6% | 0.14% | +70.9% |
| Q4 2015 | $529,122,000 | – | 8,515 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DIKER MANAGEMENT LLC | 1,084,317 | $85,509,000 | 43.23% |
| Leonard Green & Partners, L.P. | 2,100,000 | $165,606,000 | 2.29% |
| Champlain Investment Partners, LLC | 3,952,620 | $311,704,000 | 1.79% |
| Brown Capital Management | 2,454,770 | $193,583,000 | 1.34% |
| Aurora Investment Counsel | 19,502 | $1,538,000 | 1.24% |
| Conestoga Capital Advisors, LLC | 797,481 | $62,889,000 | 1.00% |
| EMERALD ADVISERS, LLC | 292,554 | $23,071,000 | 0.77% |
| FRED ALGER MANAGEMENT, LLC | 3,470,340 | $273,671,000 | 0.71% |
| GENEVA CAPITAL MANAGEMENT LLC | 510,171 | $40,232,000 | 0.68% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 7,650 | $603,000 | 0.58% |